Your browser doesn't support javascript.
loading
Is Higher Docetaxel Clearance in Prostate Cancer Patients Explained by Higher CYP3A? An In Vivo Phenotyping Study with Midazolam.
van der Heijden, Lisa T; Ribbers, Claire A; Vermunt, Marit A C; Pluim, Dick; Acda, Manon; Tibben, Matthijs; Rosing, Hilde; Douma, Joeri A J; Naipal, Kishan; Bergman, Andre M; Beijnen, Jos H; Huitema, Alwin D R; Opdam, Frans L.
Afiliación
  • van der Heijden LT; Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Ribbers CA; Division of Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Vermunt MAC; Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Pluim D; Division of Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Acda M; Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
  • Tibben M; Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Rosing H; Division of Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Douma JAJ; Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Naipal K; Division of Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Bergman AM; Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Beijnen JH; Division of Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Huitema ADR; Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Opdam FL; Division of Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute, Amsterdam, The Netherlands.
J Clin Pharmacol ; 64(2): 155-163, 2024 Feb.
Article en En | MEDLINE | ID: mdl-37789682
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Citocromo P-450 CYP3A Límite: Humans / Male Idioma: En Revista: J Clin Pharmacol Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Citocromo P-450 CYP3A Límite: Humans / Male Idioma: En Revista: J Clin Pharmacol Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos